Drugmaker, Retailers Strike Deal In Loestrin Antitrust MDL
Lupin Pharmaceuticals cut a deal that will allow it to escape antitrust claims leveled against it by Walgreens, CVS and other retailers that it conspired with two other pharmaceutical companies to keep...To view the full article, register now.
Already a subscriber? Click here to view full article